RAPID DIAGNOSTICS MARKET ANALYSIS

Rapid Diagnostics Market, By Product (Consumables and Instruments/Analysers), By Prescription (Professional Diagnostics and At-Home/OTC-Based Testing), By Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug of Abuse Testing, and Pregnancy and Fertility/Ovulation Testing), By End User (Hospitals and Clinics, Laboratories, Individuals/Home Healthcare Settings, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : May 2023
Code : CMI5691
Pages :168
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Leading Companies

Global Rapid Diagnostics Market: Key Companies Insights

The global rapid diagnostics market is highly competitive. This is attributed to the rise in demand for rapid diagnostics testing devices across the globe, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global rapid diagnostics market are Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings.

Rapid Diagnostics Market Report Snapshots

RAPID DIAGNOSTICS MARKET ANALYSIS

Leading Companies

EXISTING CLIENTELE